rms given pressure on respiratory/diabetes, failure of key pipeline drugs and failure to deliver expected margin improvements from new launches. ■ B&M - BMEB.L: Downside risks relate to B&M's ability to open profitable new stores, eg rising rents and success in the relatively untested Southern England. Oth